Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1919.8000 -43.70 (-2.23%)
NSE Sep 26, 2025 15:31 PM
Volume: 1.1M
 

logo
Lupin Ltd.
07 Aug 2017
1919.80
-2.23%
BP Wealth
Lupin posted revenues of Rs 38.7bn with decline of 12.8% YoY growth which was below our estimate of Rs 42.58bn (~9.1% below est.). EBITDA margin, at 19.9%, was below our estimate of 23.5%, mainly due to 3.2 % decline in gross margin (GST impacted 2.5% of gross margin). R&D; expense stood at...
Number of FII/FPI investors increased from 979 to 987 in Jun 2025 qtr.
More from Lupin Ltd.
Recommended